Oppenheimer Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-12,636
| Closed | -$364K | – | 1154 |
|
|
2024
Q3 | $364K | Sell |
12,636
-118
| -0.9% | -$3.4K | ﹤0.01% | 946 |
|
|
2024
Q2 | $489K | Buy |
12,754
+4,060
| +47% | +$156K | 0.01% | 867 |
|
|
2024
Q1 | $511K | Buy |
8,694
+664
| +8% | +$39K | 0.01% | 825 |
|
|
2023
Q4 | $481K | Sell |
8,030
-1,839
| -19% | -$110K | 0.01% | 871 |
|
|
2023
Q3 | $375K | Buy |
9,869
+3,673
| +59% | +$140K | 0.01% | 921 |
|
|
2023
Q2 | $564K | Sell |
6,196
-129
| -2% | -$11.8K | 0.01% | 836 |
|
|
2023
Q1 | $417K | Buy |
+6,325
| New | +$417K | 0.01% | 890 |
|